Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Stabach

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Cell Science|February 24, 2006
Human Sec31B: a family of new mammalian orthologues of yeast Sec31p that associate with the COPII coatMichael C Stankewich, Paul R Stabach, Jon S Morrow
The Journal of Surgical Research|May 27, 2005
Expression of ZER6 in ERalpha-positive breast cancerPaul R Stabach, Manimekalai M Thiyagarajan, Ronald J Weigel
American Journal of Physiology. Cell Physiology|September 5, 2008
Ankyrin facilitates intracellular trafficking of alpha1-Na+-K+-ATPase in polarized cellsPaul R Stabach, Prasad Devarajan, Michael C Stankewich, et al.
Biochemical and Biophysical Research Communications|January 19, 2010
Ankyrin recognizes both surface character and shape of the 14-15 di-repeat of beta-spectrinPenelope J La-Borde, Paul R Stabach, Ivana Simonović, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2024
Novel treatment for PXE: Recombinant ENPP1 enzyme therapyIda Joely Jacobs, Dora Obiri-Yeboah, Paul R Stabach, et al.
Journal of Cell Science|December 14, 2011
Cell organization, growth, and neural and cardiac development require αII-spectrinMichael C Stankewich, Carol D Cianci, Paul R Stabach, et al.
Journal of Cell Science|March 23, 2006
Stimulation of Galphaq-coupled M1 muscarinic receptor causes reversible spectrin redistribution mediated by PLC, PKC and ROCKMiyoko Street, Stephen J Marsh, Paul R Stabach, et al.
Blood|January 27, 2009
The structure of the ankyrin-binding site of beta-spectrin reveals how tandem spectrin-repeats generate unique ligand-binding propertiesPaul R Stabach, Ivana Simonović, Miranda A Ranieri, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 11, 2025
Improvements in hearing loss with bone-targeted enzyme replacement therapy are associated with corrected hypomineralization and osteocyte properties of auditory ossicles in Enpp1-deficient miceAna Ocokoljic, Shivani Srivastava, Simon von Kroge, et al.
Frontiers in Chemistry|May 2, 2022
Strategies for Glycoengineering Therapeutic ProteinsKris Dammen-Brower, Paige Epler, Stanley Zhu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Cell Science|February 24, 2006
Human Sec31B: a family of new mammalian orthologues of yeast Sec31p that associate with the COPII coatMichael C Stankewich, Paul R Stabach, Jon S Morrow
The Journal of Surgical Research|May 27, 2005
Expression of ZER6 in ERalpha-positive breast cancerPaul R Stabach, Manimekalai M Thiyagarajan, Ronald J Weigel
American Journal of Physiology. Cell Physiology|September 5, 2008
Ankyrin facilitates intracellular trafficking of alpha1-Na+-K+-ATPase in polarized cellsPaul R Stabach, Prasad Devarajan, Michael C Stankewich, et al.
Biochemical and Biophysical Research Communications|January 19, 2010
Ankyrin recognizes both surface character and shape of the 14-15 di-repeat of beta-spectrinPenelope J La-Borde, Paul R Stabach, Ivana Simonović, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2024
Novel treatment for PXE: Recombinant ENPP1 enzyme therapyIda Joely Jacobs, Dora Obiri-Yeboah, Paul R Stabach, et al.
Journal of Cell Science|December 14, 2011
Cell organization, growth, and neural and cardiac development require αII-spectrinMichael C Stankewich, Carol D Cianci, Paul R Stabach, et al.
Journal of Cell Science|March 23, 2006
Stimulation of Galphaq-coupled M1 muscarinic receptor causes reversible spectrin redistribution mediated by PLC, PKC and ROCKMiyoko Street, Stephen J Marsh, Paul R Stabach, et al.
Blood|January 27, 2009
The structure of the ankyrin-binding site of beta-spectrin reveals how tandem spectrin-repeats generate unique ligand-binding propertiesPaul R Stabach, Ivana Simonović, Miranda A Ranieri, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 11, 2025
Improvements in hearing loss with bone-targeted enzyme replacement therapy are associated with corrected hypomineralization and osteocyte properties of auditory ossicles in Enpp1-deficient miceAna Ocokoljic, Shivani Srivastava, Simon von Kroge, et al.
Frontiers in Chemistry|May 2, 2022
Strategies for Glycoengineering Therapeutic ProteinsKris Dammen-Brower, Paige Epler, Stanley Zhu, et al.
Pageof 2